Lauer Wealth LLC Sells 243 Shares of CVS Health Co. (NYSE:CVS)

Lauer Wealth LLC trimmed its holdings in shares of CVS Health Co. (NYSE:CVS) by 4.0% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,760 shares of the pharmacy operator’s stock after selling 243 shares during the period. Lauer Wealth LLC’s holdings in CVS Health were worth $259,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also modified their holdings of the company. Edgestream Partners L.P. purchased a new position in CVS Health in the second quarter valued at about $1,140,000. E Fund Management Co. Ltd. boosted its holdings in shares of CVS Health by 11.0% in the 2nd quarter. E Fund Management Co. Ltd. now owns 4,722 shares of the pharmacy operator’s stock valued at $279,000 after buying an additional 467 shares in the last quarter. Marathon Trading Investment Management LLC purchased a new position in shares of CVS Health in the 2nd quarter worth approximately $1,412,000. WCG Wealth Advisors LLC lifted its position in CVS Health by 24.4% during the second quarter. WCG Wealth Advisors LLC now owns 28,866 shares of the pharmacy operator’s stock valued at $1,705,000 after acquiring an additional 5,668 shares during the last quarter. Finally, Mark Sheptoff Financial Planning LLC boosted its stake in CVS Health by 46.9% in the second quarter. Mark Sheptoff Financial Planning LLC now owns 5,249 shares of the pharmacy operator’s stock valued at $310,000 after acquiring an additional 1,677 shares in the last quarter. Institutional investors own 80.66% of the company’s stock.

CVS Health Price Performance

Shares of CVS opened at $52.01 on Friday. The business’s 50-day moving average is $51.49 and its two-hundred day moving average is $56.39. The company has a market capitalization of $65.44 billion, a P/E ratio of 13.20, a P/E/G ratio of 0.72 and a beta of 0.59. CVS Health Co. has a fifty-two week low of $43.56 and a fifty-two week high of $80.75. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.59 and a current ratio of 0.80.

CVS Health (NYSE:CVS) last posted its earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 EPS for the quarter, topping the consensus estimate of $1.08 by $0.01. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. The firm had revenue of $95.43 billion for the quarter, compared to analyst estimates of $92.72 billion. During the same period last year, the company earned $2.21 earnings per share. CVS Health’s revenue for the quarter was up 6.3% compared to the same quarter last year. Research analysts predict that CVS Health Co. will post 5.22 earnings per share for the current year.

CVS Health Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Monday, February 3rd. Investors of record on Thursday, January 23rd will be issued a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a yield of 5.11%. The ex-dividend date is Thursday, January 23rd. CVS Health’s dividend payout ratio (DPR) is presently 67.51%.

Analyst Ratings Changes

A number of equities analysts have recently issued reports on CVS shares. StockNews.com downgraded CVS Health from a “hold” rating to a “sell” rating in a research report on Thursday, November 14th. Piper Sandler reduced their target price on CVS Health from $72.00 to $64.00 and set an “overweight” rating on the stock in a research report on Monday, November 25th. Cantor Fitzgerald reissued a “neutral” rating and issued a $62.00 price target on shares of CVS Health in a report on Tuesday, October 1st. Mizuho cut their price objective on shares of CVS Health from $73.00 to $66.00 and set an “outperform” rating on the stock in a report on Thursday, October 24th. Finally, Wells Fargo & Company raised shares of CVS Health from an “equal weight” rating to an “overweight” rating and increased their price objective for the company from $60.00 to $66.00 in a research report on Monday, November 18th. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and thirteen have assigned a buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $68.71.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.